Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ting Lu
Observed names:
Lu, Ting,
Ting Wei Lu
Institution:
The University of Texas at San Antonio Health Science Center
Observed institutions:
The University of Texas at San Antonio Health Science Center,
Second Affiliated Hospital of Chongqing Medical University,
Institute of Bioengineering and Nanotechnology
ORCID:
0000-0001-8880-764X
Observed ORCID:
0000-0001-8880-764X
OpenAlex ID:
A5076422528
Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV
2022
·
Ling Ao
, Ting Lu
, et al.
·
Emerging Microbes & Infections
·
52
PDF
Therapeutic effect of a multi-targeted imidazolium compound in hepatocellular carcinoma
2014
·
Began Gopalan
, Karthikeyan Narayanan
, et al.
·
Biomaterials
·
14
Increasing and sustaining discharges by noon – a multi-year process improvement project
2024
·
Ryan Bailey
, Ankur Segon
, et al.
·
BMC Health Services Research
·
10
PDF
Dynamic immunogenicity after primary and booster inactivated SARS‐CoV‐2 vaccination in people living with HIV: A longitudinal observational study
2023
·
Ting Lu
, Zhiwei Chen
, et al.
·
Journal of Medical Virology
·
8
PDF
Analysis of risk factors of Omicron infection and antibody response in people with HIV: a multi-center cross-sectional study
2024
·
Ni Wang
, Dazhi Zhang
, et al.
·
Research Square
PDF
Comparative efficacy and safety analysis of sorafenib in patients with advanced hepatocellular cancer (HCC) with varying liver dysfunction: A south Texas institutional analysis.
2013
·
Raed Moh'd Taiseer Al-Rajabi
, Norma Ketchum
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
11
Citation count:
84
H-index:
4
I10-index:
3
Year
Topic
Type